Orthofix Medical Inc.

OFIX

US68752M1080

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
12.99 ^USD	-0.84%		-0.84%	-3.64%

Apr. 16	Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	CI
Apr. 12	Orthofix Medical Inc. Announces Board Resignation	CI

Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600 Health Care

December 18, 2023 at 12:00 am EST

Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600 Health Care (Sector)

Latest news about Orthofix Medical Inc.

Orthofix Medical Inc. Appoints Andres Cedron as New Chief Legal Officer	Apr. 16	CI
Orthofix Medical Inc. Announces Board Resignation	Apr. 12	CI
Orthofix Medical Inc. Appoints Lucas Vitale as Chief People and Business Operations Officer	Mar. 18	CI
Orthofix Medical Q4 Loss Widens, Sales Rise; 2024 Sales Outlook Set	Mar. 05	MT
Orthofix Medical Inc. Provides Revenue Guidance for the First Quarter, Second Quarter and Third Quarter of 2024	Mar. 05	CI
Transcript : Orthofix Medical Inc., Q4 2023 Earnings Call, Mar 05, 2024	Mar. 05
Orthofix Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 05	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Reports Q4 Revenue $200.4M, vs. Street Est of $195.6M	Mar. 05	MT
Orthofix Medical Guides For 2024 Sales of $785-$795 Million, vs CIQ Analyst Consensus of $799 Million	Mar. 05	MT
Orthofix Medical Inc. Provides Earnings Guidance for the Year 2024	Mar. 05	CI
Orthofix Medical Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2023	Mar. 05	CI
Orthofixan Signs Deal to Distribute BoneMRI Imaging Software in US	Jan. 18	MT
Orthofix Announces Commercial Partnership with MRIguidance	Jan. 18	CI
Earnings Flash (OFIX) ORTHOFIX MEDICAL Posts Q4 Revenue $200.3M	Jan. 09	MT
Orthofix Medical Inc. Names Massimo Calafiore as President and Member of the Board of Directors Effective Immediately	Jan. 08	CI
Orthofix Medical Inc. Names Massimo Calafiore as Chief Executive Officer	Jan. 08	CI
Orthofix Medical Inc. Appoints Julie Andrews as Chief Financial Officer	Jan. 08	CI
Orthofix Announces Publication of New Data Supporting Use of PEMF Stimulation in Lumbar Spine Fusion Procedures for Patients at Risk of Pseudarthrosis	Dec. 21	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 1000	Dec. 18	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600 Health Care	Dec. 18	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P 600	Dec. 18	CI
Orthofix Medical Inc.(NasdaqGS:OFIX) dropped from S&P Composite 1500	Dec. 18	CI
Orthofix Medical Inc. Announces Board Changes	Dec. 15	CI
Engine Capital Management Enters into a Cooperation Agreement with Orthofix Medical	Dec. 13	CI
Uber Technologies, Jabil, Builders First Source to Join S&P 500 on Dec. 18, Other Index Changes	Dec. 04	MT

Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company operates through two segments: Global Spine and Global Orthopedics. The Global Spine segment consists of three product categories: Bone Growth Therapies, Spinal Implants, and Biologics. The Global Orthopedics segment offers products and solutions that allow physicians to treat a variety of orthopedic conditions specifically related to limb reconstruction and deformity correction unrelated to the spine. Global Orthopedics distributes its products globally through a network of distributors and sales representatives to sell orthopedic products to hospitals and healthcare providers. It has a portfolio of biologics, spinal hardware, bone growth therapies, specialized orthopedic solutions, and surgical navigation system. Its products are distributed in 68 countries globally via the Company's sales representatives and distributors.

Sector

Medical Equipment, Supplies & Distribution

Calendar

2024-05-06 - Q1 2024 Earnings Release

Related indices

Russell 2000

More about the company

Income Statement Evolution

More financial data

Ratings for Orthofix Medical Inc.

Trading Rating

Investor Rating

ESG Refinitiv

C+

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

12.99 USD

Average target price

18.47 USD

Spread / Average Target

+42.16%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
ORTHOFIX MEDICAL INC.	-3.64%	486M
ABBOTT LABORATORIES	-2.31%	187B
MEDTRONIC PLC	-3.20%	106B
BECTON, DICKINSON AND COMPANY	-5.04%	66.9B
DEXCOM, INC.	+0.20%	49.45B
CENCORA, INC.	+17.29%	48B
HOYA CORPORATION	+4.06%	40.84B
METTLER-TOLEDO INTERNATIONAL, INC.	+2.07%	26.48B
WEST PHARMACEUTICAL SERVICES, INC.	+2.36%	26.25B
TERUMO CORPORATION	+12.96%	24.62B

Other Medical Equipment, Supplies & Distribution